MEDX

Investor Moves

Name	Value	Action	Change	Price	Current Price
Ken GriffinCitadel Advisors $-488.0K ExitQ2 2025 $488k -- --
Ken GriffinCitadel Advisors $143.7K AddQ1 2025 $144k -- --

News

globenewswire.comMEDX HOLDINGS REPORTS STRONG Q4 RESULTS, ACHIEVES NET PROFITABILITY, AND ANNOUNCES STRATEGIC PARTNERSHIPS TO SUPERCHARGE FRANCHISE EXPANSIONglobenewswire.comApr 7

Trade MEDX

About Horizon Kinetics Medical ETF

The Horizon Kinetics Medical ETF (MEDX) is structured to achieve significant long-term growth for investors. It accomplishes this by primarily focusing its investments on cutting-edge, patented pharmaceutical and biologic treatments that are considered first-line therapies. The fund aims to generate profits by recognizing and capitalizing on the inherent, underlying value of these companies, as well as benefiting from impactful advancements in medical science.

IPO Date: Jan 31, 2023

Market Data

Open: $33.90
High: $33.90
Low: $33.88
Volume: 428
Avg Volume: 1.4K
52W High: $35.46
52W Low: $26.42

Valuation

Market Cap: $18M
Dividend Yield: 40.9%

Financials

Financial statement snapshot is not available yet.

Events

DividendDec 23

$0.4088